ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Luiz Boro Puig
Sérgio Almeida de Oliveira
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Puig, L. B.
Right arrow Articles by de Oliveira, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Puig, L. B.
Right arrow Articles by de Oliveira, S. A.
Related Collections
Right arrow Valve disease

Ann Thorac Surg 2001;72:615-617
© 2001 The Society of Thoracic Surgeons

Case report

Tricuspid dura mater bioprostheses: more than 20-year follow-up of 3 patients

Luiz Boro Puig, MDa, Carlos Manuel de Almeida Brandão, MDa, Pablo Maria Alberto Pomerantzeff, MDa, Fábio Antônio Gaiotto, MDa, Sérgio Almeida de Oliveira, MDa

a Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil

Accepted for publication July 16, 2000.

Address reprint requests to Dr Puig, Heart Institute (InCor), University of São Paulo Medical School, Av Dr Enéas de Carvalho Aguiar, 44, 05403-000 São Paulo, Brazil
e-mail: lpuig{at}incor.usp.br

Replacement of the tricuspid valve is sometimes necessary. We report 3 consecutive patients with tricuspid insufficiency who underwent valve replacement with glycerol-preserved, homologous dura mater cardiac bioprostheses between 1971 and 1973. The first 2 patients are well 28 and 27 years later; the last patient was lost to follow-up after 20 years. We conclude that preservation of homologous dura mater bioprostheses in glycerol may reduce rates of thromboembolism, thrombosis, and structural dysfunction during the late postoperative period.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 by The Society of Thoracic Surgeons.